Crossmark

The efficacy and safety of lecanemab 10 mg/kg biweekly compared to a placebo in patients with Alzheimer’s disease: a systematic review and meta-analysis of randomized controlled trials

Crossref DOI link: https://doi.org/10.1007/s10072-024-07477-w

Published Online: 2024-04-03

Published Print: 2024-08

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Abdelazim, Karim https://orcid.org/0000-0001-6598-9188
Allam, Ahmed A. https://orcid.org/0009-0001-4143-9496
Afifi, Badreldin https://orcid.org/0009-0003-0503-5587
Abdulazeem, Hebatullah https://orcid.org/0000-0002-4529-7114
Elbehiry, Ahmed I.
Funding

Funding for this research was provided by:

Alexandria University
License Information

Text and Data Mining valid from 2024-04-03

Version of Record valid from 2024-04-03
More Information

Article History

Received: 27 December 2023

Accepted: 16 March 2024

First Online: 3 April 2024

Declarations

:

: Not applicable.

: Not applicable.

: Not applicable.

: The authors declare no competing interests.

Document is current

Any future updates will be listed below